Slate Path Capital
New York City, New Yorkslatepathcapital.com
Overview
Slate Path Capital is a global long/short equity hedge fund manager that aims for long-term, risk-adjusted capital growth using a fundamental, research-based security selection process.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| City Therapeutics | Jun 2026 | Series B | Co-investor |
| City Therapeutics | Oct 2024 | Series A | Co-investor |
| Tvardi | Jun 2021 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?